alopecia

Posts

Alopecia Treatment Market 2019

Alopecia Treatment Market – Global Industry Analysis

Alopecia Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

A sedentary lifestyle, unhealthy eating habits, and growing stress levels are increasingly responsible for severe hair loss and damage, also known as alopecia.

Ageing, hormonal imbalance, and increasing prevalence of cancer, arthritis, hypertension, and depression are other factors causing alopecia.

Thus, the alopecia treatment market is anticipated to witness significant growth in the coming years owing to a surge in the prevalence of alopecia. The number of people seeking alopecia treatment is extremely high in developed nations.

However, increased healthcare expenditure has spurred the demand for alopecia treatment in developing nations such as China and India as well.

The alopecia treatment market is segmented on the basis of product, gender, end user, and geography. By product, the market is segmented into shampoos and conditioners, vitamins and supplements, and other (gels, oils, and serums). On the basis of end user, the market is segmented into homecare settings, dermatology clinics, and others.

The report covers exhaustive analysis on the alopecia treatment market segments, including the leading, declining, and fastest growing segments. It comprises the analysis of market dynamics, the market size and forecast, and the trends, threats, and opportunities.

The study also comprises the vendor landscape, degree of competition, threat of new entrants, and the bargaining power of buyers and suppliers.

Overview of the Alopecia Treatment Market

According to the American Hair Loss Association, 95% of the hair loss in men is caused by androgenetic alopecia. The Association also states moreover, the body also states that around 800 thousand people are undergoing some form of treatment for hair loss across the globe.

The rise in the geriatric population and increasing hypertension and depression among the middle-aged population are some of the factors driving the alopecia treatment market. Growing demand for surgical hair transplant is expected to drive the global alopecia treatment market in the coming years.

An increase in the disposable income of the people, technological advancements in hair treatment medical devices, and a growing emphasis on looking good are some of the other factors driving the market. Moreover, the easy accessibility to scalp treatment is also helping the market to grow.

The global alopecia treatment market is expected to be restricted by the high cost of medications. The probable side effects, reactions, and allergies caused by alopecia treatments will further hamper the growth of the market. Decreased libido, high BP, increase in the heart rate, and erectile dysfunction is some of the side effects caused by alopecia treatment, threatening the market’s growth. However, technological advancements and the development of novel therapeutic drugs are expected to bring new opportunities for growth in the market.

On the basis of geography, the global alopecia treatment market is segmented into Europe, Asia Pacific, North America, and the Rest of the World, of which North America is currently the largest segment. North America is also the most significant revenue generator at present, owing to the rise in hair loss among people and the high treatment rates. The high disposable income of the people and the availability of innovative therapeutic solutions are also factors driving the growth of the market in North America.

Companies Mentioned in the Report

The report profiles leading players in the global alopecia treatment market. Important information pertaining to players, such as their recent developments, product picture, specifications, and price, and the challenges faced by them are included. Additionally, the report covers strategies adopted by key players to grow in the alopecia treatment market.

The key vendors include Vitabiotics, Sun Pharma, Merck & Co., Alpecin, Dr. Reddy’s Laboratories, Cipla, Johnson & Johnson, Kirkland Signature, Phyto Ales Group, and Lifes2good.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market

Alopecia Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

 

Source

Previous Posts

Alopecia Treatment Market 2019

Alopecia Treatment Market – Global Industry Analysis

Alopecia Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

A sedentary lifestyle, unhealthy eating habits, and growing stress levels are increasingly responsible for severe hair loss and damage, also known as alopecia.

Ageing, hormonal imbalance, and increasing prevalence of cancer, arthritis, hypertension, and depression are other factors causing alopecia.

Thus, the alopecia treatment market is anticipated to witness significant growth in the coming years owing to a surge in the prevalence of alopecia. The number of people seeking alopecia treatment is extremely high in developed nations.

However, increased healthcare expenditure has spurred the demand for alopecia treatment in developing nations such as China and India as well.

The alopecia treatment market is segmented on the basis of product, gender, end user, and geography. By product, the market is segmented into shampoos and conditioners, vitamins and supplements, and other (gels, oils, and serums). On the basis of end user, the market is segmented into homecare settings, dermatology clinics, and others.

The report covers exhaustive analysis on the alopecia treatment market segments, including the leading, declining, and fastest growing segments. It comprises the analysis of market dynamics, the market size and forecast, and the trends, threats, and opportunities.

The study also comprises the vendor landscape, degree of competition, threat of new entrants, and the bargaining power of buyers and suppliers.

Overview of the Alopecia Treatment Market

According to the American Hair Loss Association, 95% of the hair loss in men is caused by androgenetic alopecia. The Association also states moreover, the body also states that around 800 thousand people are undergoing some form of treatment for hair loss across the globe.

The rise in the geriatric population and increasing hypertension and depression among the middle-aged population are some of the factors driving the alopecia treatment market. Growing demand for surgical hair transplant is expected to drive the global alopecia treatment market in the coming years.

An increase in the disposable income of the people, technological advancements in hair treatment medical devices, and a growing emphasis on looking good are some of the other factors driving the market. Moreover, the easy accessibility to scalp treatment is also helping the market to grow.

The global alopecia treatment market is expected to be restricted by the high cost of medications. The probable side effects, reactions, and allergies caused by alopecia treatments will further hamper the growth of the market. Decreased libido, high BP, increase in the heart rate, and erectile dysfunction is some of the side effects caused by alopecia treatment, threatening the market’s growth. However, technological advancements and the development of novel therapeutic drugs are expected to bring new opportunities for growth in the market.

On the basis of geography, the global alopecia treatment market is segmented into Europe, Asia Pacific, North America, and the Rest of the World, of which North America is currently the largest segment. North America is also the most significant revenue generator at present, owing to the rise in hair loss among people and the high treatment rates. The high disposable income of the people and the availability of innovative therapeutic solutions are also factors driving the growth of the market in North America.

Companies Mentioned in the Report

The report profiles leading players in the global alopecia treatment market. Important information pertaining to players, such as their recent developments, product picture, specifications, and price, and the challenges faced by them are included. Additionally, the report covers strategies adopted by key players to grow in the alopecia treatment market.

The key vendors include Vitabiotics, Sun Pharma, Merck & Co., Alpecin, Dr. Reddy’s Laboratories, Cipla, Johnson & Johnson, Kirkland Signature, Phyto Ales Group, and Lifes2good.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market

Alopecia Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

 

Source

Previous Posts

Global Alopecia Treatment Market

Global Alopecia Treatment Market

Global Alopecia Treatment Market– Industry Trends and Forecast to 2026

The Global Alopecia Treatment (Hair Loss) Market is expected to rise from its initial estimated value of USD 8.21 billion in 2018 to an estimated value of USD 12.40 billion by 2026 registering a CAGR of 5.3% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising geriatric population along with high demand for surgical hair transplant and changing lifestyle.
Market Definition: Global Alopecia Treatment (Hair Loss) Market

Alopecia areata is a medical condition which is a type of alopecia which attacks the hair follicles causes the breakage or fall of hair leading to complete baldness. The patient suffering from alopecia areata, their scalp becomes patchy, diffused and confluent pattern leading the hair fall initially and later spread over the entire scalp termed as alopecia totalis or entire epidermis.

Alopecia areata is an autoimmune hair loss on the scalp or on the body and commonly it shows in the form of solitary and multiple patches of alopecia.

Market Drivers:

Rising geriatric population along with high demand for surgical hair transplant will boost the market
Changing lifestyle along with increase in stress level among working class population can fuel the growth of the market

Market Restraints:

High cost of alopecia treatment (hair loss) is acting as a major restraint for the market
Side effects/allergic reactions by treatment also acting as a major market restraint.

Segmentation: Global Alopecia Treatment (Hair Loss) Market

By Disease Type
Androgenic Alopecia
Alopecia Areata
Ciatricial Alopecia
Traction Alopecia
Alopecia Totalis
By Drug Type
Minoxidil
Finasteride
Cyclosporine
Others
By Gender
Male
Female
By Route of Administration
Oral
Topical
Injectable
By Distribution Channel
Hospital
Retail Pharmacies
Online Pharmacies
By Geography
North America
US
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
South Korea
India
Australia
Singapore
Malaysia
Indonesia
Thailand
Philippines
Rest of Asia-Pacific
The Middle East and Africa
South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of the Middle East and Africa

Key Developments in the Market:

In January, 2018, Concert Pharmaceuticals, Inc. announced U.S. FDA granted Fast Track designation for CTP-543, a novel, oral Janus kinase (JAK) inhibitor for the treatment of moderate-to-severe alopecia areata, a disease which attacks the hair follicles, leading to hair loss.
In May 2018, Histogen, Inc (U.S.) announced that received approval to Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to study its lead product in female diffuse hair loss.
In March 2017, Perrigo Perrigo Company PLC (U.S.) announced the launch of over-the-counter Women’s Rogaine, which helps to regrow hair on top of the scalp.

Competitive Analysis: Global Alopecia Treatment (Hair Loss) Market

The global alopecia treatment (hair loss) market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of alopecia treatment (hair loss) market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.
Key Market Competitors: Global Alopecia Treatment (Hair Loss) Market

Few of the major market competitors currently working in the alopecia treatment (hair loss) market are Cipla, Viviscal, Dr. Reddy’s Laboratories Ltd., Regaine, Merck & Co., Inc, Ranbaxy Laboratories Ltd, Phyto – Alès Groupe, Kirkland Signature, Vitabiotics, Nanogen, Alpecin – Dr. Kurt Wolff GmbH & Co. KG, Rogaine – Johnson and Johnson, Histogen, Inc., Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., HCell Inc., GlaxoSmithKline plc., Perrigo Company PLC. and Daiichi Sankyo, Inc.
Research Methodology: Global Alopecia Treatment (Hair Loss) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents:

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report:

Current and future of global alopecia treatment (hair loss) market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds the highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at the country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

 

Global Alopecia Treatment Market– Industry Trends and Forecast to 2026

Source

Previous Posts

Alopecia Drugs Market 2018

Alopecia Drugs Market 2018

Alopecia Drugs Market 2018 Globally With Net Revenue Worth US$ 10,992.9 Mn in 2026

The global alopecia drugs market is projected to reach a value of over US$ 10,000 Mn in 2026 at a CAGR of 4.8% over the forecast period. The report also offers insightful and detailed information regarding the various key players operating in the global alopecia drugs market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global alopecia drugs market report has been segmented on the basis of type, material, design, application, and region.

Alopecia is a hair loss condition which affects the scalp of individuals. It causes clumps of hair to fall out resulting in hairless patches on the scalp or other areas of the body. In some cases, individuals affected by alopecia may have thinner hair leading to unnoticeable patches of baldness, leaving short snubs called exclamation point hair.

Alopecia drugs have proven useful in treating hair loss conditions to a significant extent in both males and females. The drugs are prescribed by healthcare professionals depending on the type of alopecia, age, and extent of hair loss.

The recent announcement of ‘Worldwide Alopecia Drugs Market’ begins with a description of the product, definition, scope of product and classification, specifications and market outlook. The report provides a forecast period from 2017 to 2026. It includes a thorough analysis of market growth factors, static data, the top manufacturers/major players, and geographical region-wise analysis.

It analyses historical alopecia drugs market values to work on the latest market needs and estimate future market propensity. It composes of development plans and policies of each and every key player along with their manufacturing processes and distinct approaches used during the process.

Increasing incidence of hair loss in both males and females across the globe is a key factor driving the growth of the global market over the forecast period. For instance, the American Academy of Dermatology stated that around 80 million people suffered from hair loss problems in the US alone in 2016.

Another factor fueling global market is increasing awareness among individuals pertaining to availability of various treatments in the market, which can be attributed to the initiatives taken by several regulatory bodies such as the National Alopecia Areata Foundation (NAAF) and the American Hair Loss Association (AHLA). Rapunzel Project is an initiative by AHLA which works to prevent hair loss in chemotherapy patients. Furthermore, approval of janus kinase inhibitors (JAK) drugs with minimal side effects by FDA is another factor expected to impel growth of target market in the near future.

Global alopecia drugs market division:

Global alopecia drugs market analysis by segments:

Global market segmentation by type: Alopecia areata, Alopecia totalis, Alopecia Universalis. Global market segmentation by product type: Topical, Oral, Injectable. Global market segmentation by the end user: Hospitals and clinics, Salons, Home care

Global alopecia drugs market study by players/vendors:  Cipla Inc, Reddy’s Laboratories Ltd., Johnson & Johnson, Merck & Co., Ranbaxy Laboratories Ltd., The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Sun Pharmaceutical Industries Ltd., Others

Regional Analysis:

Vital Regions that operate alopecia drugs market covers Latin America (Colombia, Argentina and Brazil), North America (Mexico, Canada and The United States), market in Asia-Pacific (China, Japan, Korea, India and South-East Asia), Europe (UK, Russia, Germany and Italy), The Middle East and Africa (South Africa, UAE, Egypt and Saudi Arabia). Besides, production value and volume, market share, market value, import/export detailing, price/cost, market growth analysis and SWOT analysis.

The research methodology used to obtain crucial information for alopecia drugs market:

The research methodology of alopecia drugs market includes not only primary but also secondary research information sources. It carries out distinct factors affecting industry such as market environment, various government policies, historical data, and latest trends, technological advancement, future innovations, market risk factors, market restraints, challenges, opportunities and any technical evolution in industry. Research analysts initially collect the data from distinct trivial information sources such as financial reports of the company, internet, magazines and research reports.

Alopecia Drugs Market 2018 Globally With Net Revenue Worth US$ 10,992.9 Mn in 2026

Source

 

Previous Posts

 

Hair Loss and Balding in Women

Nolopecia Balding and Prostate Cancer

Balding and Prostate Cancer: Lilac Corp reviews a study and recommends Nolopecia, a natural treatment for hair loss

All natural hair loss supplement sold by Lilac Corp

Lilac Corp reviews a study that tested a possible link between early hair loss and prostate cancer.

Nolopecia, targets the latent viruses in the body. This helps the body maintain a normal level of the 5alpha-R, DHT, and AR proteins. A normal level of these proteins stimulates hair growth.”

A study showed that men with very early onset balding are more likely to develop aggressive prostate cancer, and at a younger age [1]. Some prostate cancers are more dangerous than others. Prostate cancer and androgenic alopecia, also called male pattern baldness, are both dependent on androgen hormones.

The study surveyed 1,941 men and found that men balding at age 20 years had a 50% higher chance of developing aggressive prostate cancer.

Also, these men were diagnosed with cancer an average of 16 months earlier than non-balding men.

Men balding at age 40 years and older, or non-balding men did not have the increased risk. Research like this is important because it helps to identify groups of men with a higher risk for aggressive cancer.

Men who are at a higher risk can perform regular screening tests for prostate cancer and should be followed up closely with their doctor.

For men (and women), who suffer from hair loss and balding, Lilac Corp recommends the natural treatment Nolopecia. Lilac Corp is the company that invented the highly effective and unique antiviral natural treatments Gene-Eden-VIR and Novirin.

The new treatment, called Nolopecia, targets the latent viruses in the body. This helps the body maintain a normal level of the 5alpha-R, DHT, and AR proteins. A normal level of these proteins stimulates hair growth.

There are many treatments for hair loss on the market.

However, only Nolopecia targets the latent viruses that cause the increase in 5alpha-R, DHT, and AR observed in people with hair loss and balding.

About Lilac Corp:

Lilac Corp specializes in the development of biology-based patent protected natural treatments. Currently, Lilac Corp is selling four products: Gene-Eden-VIR, Novirin, Nolopecia, and Noacnin. Lilac Corp ships its products to more than 100 countries around the world.

What makes Lilac Corp special is that all its products are tested in clinical studies that follow FDA guidelines. To ensure transparency, the results of the clinical studies are published in leading scientific journals. Lilac Corp also offers a 90-day money back guarantee.

Source:
[1] Papa, N., MacInnis, R., English, D., Bolton, D., Davis, I., & Lawrentschuk, N. et al. (2017). Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study. Cancer Causes & Control, 29(1), 93-102. doi: 10.1007/s10552-017-0981-0

Source

Improved Minoxidil Formulation Safe, Effective for Androgenetic Alopecia

hair loss supplements

Pediatric Alopecia Areata Severity Linked to Serum Vitamin D

Pediatric Alopecia Areata Severity Linked to Serum Vitamin D

For pediatric patients with alopecia areata, vitamin D is negatively correlated with disease severity, number of patches, and disease duration, according to a study published online in the Journal of Cosmetic Dermatology.

Mehmet Unal, MD, and Gulsum Gonulalan, MD, from the Konya Numune Hospital in Turkey, examined vitamin D status in 20 pediatric patients with alopecia areata and 34 pediatric healthy controls. The authors assessed the correlation between vitamin D status and disease severity, number of patches, and disease duration.

The researchers found that the mean serum 25-hydroxyvitamin D concentration was 15.47±7.66 and 11.09±10.53 ng/mL in patients and controls, respectively; no statistically significant difference was seen between the groups (P =.084).

Significant, negative correlations were seen for vitamin D concentration with the Severity of Alopecia Tool score (P <.001; r, -0.831), number of patches (P <.001; r, -0.989), and disease duration (P <.001 and r, -0.997).

“Vitamin D deficiency is not the only etiologic factor in alopecia areata pathogenesis, but in the presence of other etiological factors, this deficiency can aggravate alopecia areata severity, and thus, vitamin D supplementation may be beneficial in treatment of pediatric alopecia areata,” the authors write.

Source